<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37204019</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Psychiatric comorbidities in patients suffering from systemic lupus erythematosus admitted to a tertiary care hospital in Northern India.</ArticleTitle><Pagination><StartPage>1008</StartPage><EndPage>1018</EndPage><MedlinePgn>1008-1018</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231177737</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Systemic Lupus Erythematosus (SLE) is an autoimmune disease with multiorgan involvement presenting with a myriad of symptoms, including neuropsychiatric symptoms. Although many studies have evaluated screening questionnaires based psychiatric morbidity, very few studies have used contemporary diagnostic criteria.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to evaluate the prevalence of psychiatric disorders in patients with SLE admitted to a tertiary care hospital.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 79 patients diagnosed with SLE for at least for 1&#xa0;year, who were not in delirium were assessed by a qualified psychiatrist for psychiatric morbidity as per the International Classification of Diseases, 10th Revision (ICD-10) criteria. Additionally, these patients were assessed on Patient Health Questionnaire-9 (PHQ-9) item version, Patient Health Questionnaire-15 (PHQ-15) item version, Generalized Anxiety Disorder-7 item scale and Montreal Cognitive Assessment (MoCA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">51% (<i>n</i> = 40) of the participants were diagnosed with a psychiatric diagnosis, with depressive disorders being the most common, seen in 36.7% (<i>n</i> = 29) of the participants. Additionally, 10% (<i>n</i> = 8) participants were diagnosed with adjustment disorder and 2.5% (<i>n</i> = 2) were diagnosed with anxiety (not otherwise specified). Only one patient was diagnosed with organic psychosis. On PHQ-9, 39.8% (<i>n</i> = 33) were diagnosed with depression. 44.3% (<i>n</i> = 35) expressed death wishes and/or suicidal ideations. On PHQ-15, 17.7% (<i>n</i> = 14) of the participants scored for severe somatic distress (score &gt;15). On GAD-7, 55.7% (<i>n</i> = 44) screened positive for anxiety symptoms, but only 7.6% (<i>n</i> = ) had a score of 15 or more to indicate severe anxiety. Nearly half (<i>n</i> = 43; 52%) of the participants also had cognitive impairment as assessed on MoCA, with 13.3% (<i>n</i> = 11) of the participants having scores indicating severe dementia.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with SLE have a high prevalence of psychiatric comorbidities and should be routinely screened for psychiatric morbidity. They should be appropriately treated, to improve the overall treatment outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2714-2055</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation><Identifier Source="RINGGOLD">213287</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahoo</LastName><ForeName>Swapnajeet</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation><Identifier Source="RINGGOLD">213287</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naskar</LastName><ForeName>Chandrima</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation><Identifier Source="RINGGOLD">213287</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Aman</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0813-1243</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="Y">Psychotic Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">psychiatric morbidity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37204019</ArticleId><ArticleId IdType="doi">10.1177/09612033231177737</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>